SATISH MALLIK: Open Payments
NPI 1568421451 · MOOSIC, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,044 in 218 payments from 17 companies in 2025. Trend: 2023 $3,150 · 2024 $3,360 · 2025 $3,044
Food & beverage: $3,044
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 21 | $408 |
| ABBVIE INC. | 34 | $393 |
| Neurocrine BioSciences, Inc. | 33 | $380 |
| Janssen Pharmaceuticals, Inc | 23 | $338 |
| Teva Pharmaceuticals USA, Inc. | 27 | $303 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $294 |
| Otsuka America Pharmaceutical, Inc. | 19 | $294 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $159 |
| Biogen, Inc. | 6 | $103 |
| Novo Nordisk Inc | 5 | $84 |
Products named: VRAYLAR, ARISTADA, INGREZZA, REXULTI, CAPLYTA, AUSTEDO XR, INVEGA SUSTENNA, TRINTELLIX.
Industry payments across PA — which companies pay providers there.
